Day Two: Wednesday September 18, 2019

REGISTRATION & BREAKFAST

8:00

Introduction and Summary

8:15

Biomarkers & Companion Diagnostics

8:30

Title TBA

Matthew Wongchenko

Oncology Biomarker Development

 

Genentech

9:00

Biomarkers Associated with Clinical Outcomes in ZUMA-1 Supporting Approval of Yescarta

 

Vicki Plaks
Principal Scientist, CAR-T Cell Immunotherapy, Translational Medicine

 

Kite Pharma / Gilead

9:30

Title TBA

 

Veerendra Munugalavadla
Director, Translational Medicine

 

Acerta Pharma / AstraZeneca

10:00

Next Gen. Sequencing for Next Gen. Drugs: MRD Assessment and Drug Development.

 

Catherine Sanders

Sr. Director, Scientific Liaisons

 

Adaptive Biotechnologies

MORNING REFRESHMENTS & NETWORKING

10:30

11:00

Measurable Residual Disease in Acute Myeloid Leukemia: Current State and Future Directions in Drug Development and Patient Management

 

Mark Stern

Director, Precision Medicine & CDx

 

Celgene

11:30

ONGOING RESULTS OF A PHASE 1B/2 DOSE-ESCALATION AND COHORT-EXPANSION STUDY OF THE SELECTIVE, NONCOVALENT, REVERSIBLE BRUTON’S TYROSINE KINASE INHIBITOR, VECABRUTINIB, IN B-CELL MALIGNANCIES

 

Pietro Taverna

Executive Director, Translational Medicine

 

Sunesis Pharmaceuticals

12:00

Molecular Monitoring with Signatera (RUO): Applications in MRD, treatment assessment and relapse detection

Alexey Aleshin

Medical Diretor, Oncology

Natera

LUNCH & NETWORKING

12:10

PANEL DISCUSSION

1:00

Novel Approaches

2:00

SIFbodies: A Platform for Developing Superior Cell-Depleting Therapeutics


Amit Choudhury

Principal Scientist: Preclinical Pharmacology & Translational Medicine

 

Momenta Pharmaceuticals

2:30

Therapeutic Antibodies for Hematological Malignancies

 

Angus Sinclair

VP, Oncology


IGM Biosciences

3:00

AIM ACT, a Novel Nanoparticle-based Technology that Generates Therapeutic Amounts of Functional Multi-Antigen Tumor Specific CD8+ T cells with T stem cell like, Central and Effector Phenotype in 14 days

 

Mathias Oelke

SVP, Head of Pre-Clinical and Platform Development

 

Neximmune

3:30

TBC


TBC

Speaker to be confirmed

 

Teneo Bio

SUMMARY & CLOSE OF CONFERENCE

4:00

VIEW PREVIOUS DAY

DOWNLOAD EVENT GUIDE

Complete the form below to download the PDF

NEO SYNTH International House, 24 Holborn Viaduct, London EC1A 2BN

contact@neo-synth.com

(+1) 617.500.5172

Submitting Form...

The server encountered an error.

Request received. Please allow some time for processing - You will receive a manual response within a few hours.

Your details will not be shared with a third party

Copyright © 2018 | All content produced by: Neo-Synth Ltd.

DOWNLOAD GUIDE

Complete the form below to download the PDF